<<
>>

chemotherapy in the postoperative period

To 58 patients the chemotherapy was spent adjuvantnaja. The scheme and quantity of courses of chemotherapy have been defined by references of the oncologist - himioterapevta. Treatment spent with including 5 - ftoruratsila under following schemes: 32 patients received only kselodu (kapetsitabin) 1250 mg/m 2 times a day with 1 for 14 day, each 3 weeks; to 14 patients - boljusno intraperitonialno for 10 days after operation it was entered karboplatin 150 mg through established in advance intraoperatsionno a catheter into an abdominal cavity + kseloda (kapetsitabin) 1250 mg/m 2 times a day with 1 for 14 days everyone of 3 weeks; to 7 patients - under scheme CapOX (XELOX) oksaliplatin 130 mg/m in 1 day, kseloda (kapetsitabin) on 1000 mg/m 2 times a day with 1 for 14 days everyone of 3 weeks; to 5 patients - 5-ftoruratsil 450 mg/m a day i.v. 30минутная infusion with 1 for 5 days + lejkovorin 50 mg/m a day i.v. with 1 for 5 day, each 4 weeks.

Intraabdominal himioinfuziju spent the patient with established on dooperatsionnom a stage the diagnosis crico a-cellular carcinoma of the stomach. During operation left a catheter in an abdominal cavity and entered a platinum preparation for 10 days after operation then a catheter deleted.

2.5.

<< | >>
A source: Udilova Anastas Andreevna. SURGICAL TREATMENT SICK MESTNORASPROSTRANENNYM the CARCINOMA OF THE STOMACH, Taking into account CLINICO-MORPHOLOGICAL And MOLEKULJARNO-GENETIC FACTORS. The DISSERTATION on competition of a scientific degree of the candidate of medical sciences. Moscow - 2015. 2015

More on topic chemotherapy in the postoperative period:

  1. an estimation of complications in the postoperative period
  2. complications in the postoperative period
  3. 3.7 Postoperative period.
  4. Clinico-Immunologichesky characteristics of a current of the postoperative period at the patients receiving immunomodulirujushchuju therapy
  5. CHAPTER 4. INFLUENCE of the OBEMAHIRURGICHESKY INTERVENTION With APPLICATION INTRAOPERATSIONNOJ of FLUORESCENT DIAGNOSTICS ON the CURRENT of the POSTOPERATIVE PERIOD At PATIENTS WITH MALIGNANT GLIOMAMI the BRAIN.
  6. 1.2. Influence of design [1] endoprosthesises and osteal cements for the term of its "service" in the postoperative period.
  7. 6.3 Early chemotherapy
  8. the genetic factors defining efficiency of chemotherapy
  9. § 3. The period of 1964 – the modern period
  10. 3.5.3. Quality of a life sick of muscularly-invazivnym cancer of a bladder in stage T2bN0M0G1-G3-T3aN0M0G1-G3 after organosohranjajushchego the operative treatment, receiving system chemotherapy and (or) radial therapy
  11. comparison of indicators of survival rate of patients I, II groups receiving system chemotherapy and (or) radial therapy, with patients of groups of observation IA and IIA
  12. postoperative complications.
  13. postoperative chemotherapeutic treatment.
  14. the Characteristic of postoperative complications.
  15. Diagnostics of postoperative complications.
  16. the Estimation of gravity of a condition of patients at advance of a postoperative peritonitis
  17. postoperative monitoring of patients
  18. the analysis of frequency of development of postoperative complications depending on operative measure volume
  19. postoperative monitoring of patients.